26th Feb 2008 07:00
Consort Medical PLC26 February 2008 Consort Medical plc Interim Management Statement Consort Medical plc (LSE: CSRT), formerly Bespak plc, today announces itsInterim Management Statement relating to the period to 25 February 2008. ConsortMedical will be announcing its preliminary results for the year ended 3 May 2008on 24 June 2008 The Group continues to perform in line with our expectations. We continue to seestrong sales of DiskusTM and Airtraq(R) and uptake of our HFA valves in the USahead of the end of 2008 deadline for the phase-out of CFC propellants. The FDA's decision to require dose-counters for all asthma inhalers represents asignificant market opportunity for us. Our customers are evaluating our platformdose counter technology in a number of formulations for the US market ahead ofcommercial sales beginning in 2009. The restructuring announced in November 2007 remains on track, and the lastprogramme is scheduled to exit Milton Keynes in July 2008. The terminationpayment of £11m to be received in early March from Nektar, following thewithdrawal of Exubera(R) represents a significant proportion of the costsassociated with this restructuring. For further information, please contact: Consort Medical plcJonathan Glenn, Chief Executive Tel: +44 (0) 1908 552600Paul Boughton, Acting Group Finance Director MaitlandLiz Morley or Brian Hudspith Tel: +44 (0) 20 7379 5151 Consort Medical plc is a leader in medical devices for inhaled drug delivery andanaesthesia. The Group develops drug delivery systems for the pharmaceuticalindustry and disposable airway management products for critical care settings inhospitals. Consort Medical develops and manufactures metered dose inhaler valves,actuators, compliance aids, dry powder devices, disposable facemasks, breathingcircuits and laryngeal tubes. The Group has facilities in King's Lynn and MiltonKeynes in the UK, Indianapolis, Indiana and Kent, Ohio in the US, and Mumbai,India. Consort Medical is a public company quoted on the full list of the LondonStock Exchange (LSE: CSRT). This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CSRT.L